Patrick G. Morris
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 38
- Cancer Treatment and Pharmacology 28
- Cancer Research top 1%
- Breast Cancer Treatment Studies 15
- Genetics top 2%
- Glioma Diagnosis and Treatment 13
- Immunology and Allergy top 5%
- Immunology top 5%
-
- Brain Metastases and Treatment 12
- Advanced Breast Cancer Therapies 11
- Lung Cancer Treatments and Mutations 9
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Clifford A. HudisEdi BrogiSakari VanharantaSwarnali AcharyyaThórdur ÓskarssonJoan MassaguéKatia Manova‐TodorovaMonica Fornier
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesIrelandItaly
In The Last Decade
Patrick G. Morris
130 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 2.8k
- Cancer Research 1.2k
- Genetics 535
- Immunology and Allergy 202
- Immunology 684
Countries citing papers authored by Patrick G. Morris
This map shows the geographic impact of Patrick G. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick G. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick G. Morris more than expected).
Fields of papers citing papers by Patrick G. Morris
This network shows the impact of papers produced by Patrick G. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick G. Morris. The network helps show where Patrick G. Morris may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick G. Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 2 | |
| 5 | 2020 | 57 | |
| 6 | 2019 | 17 | |
| 7 | 2018 | 1 | |
| 8 | 2017 | 6 | |
| 9 | 2016 | 4 | |
| 10 | 2015 | 162 | |
| 11 | 2014 | 80 | |
| 12 | 2013 | 57 | |
| 13 | 2013 | 316 | |
| 14 | Biological subtypes of breast cancer: current concepts and implications for recurrence patterns. | 2013 | 97 |
| 15 | 2012 | 32 | |
| 16 | 2012 | 56 | |
| 17 | A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasisbreakdown → | 2012 | 859 |
| 18 | 2011 | 70 | |
| 19 | Aromatase inhibitor strategies in metastatic breast cancer | 2009 | 2 |
| 20 | 2001 | 14 |
About Patrick G. Morris
Patrick G. Morris is a scholar working on Oncology, Cancer Research and Genetics, having authored 136 papers that have together received 5.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (38 papers), Cancer Treatment and Pharmacology (28 papers), Breast Cancer Treatment Studies (15 papers), Glioma Diagnosis and Treatment (13 papers), Brain Metastases and Treatment (12 papers), Advanced Breast Cancer Therapies (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Oncology (2.8k citations), Cancer Research (1.2k citations) and Genetics (535 citations). Patrick G. Morris has collaborated with scholars based in United States, Ireland and Italy. Frequent co-authors include Clifford A. Hudis, Edi Brogi, Sakari Vanharanta, Swarnali Acharyya, Thórdur Óskarsson, Joan Massagué, Katia Manova‐Todorova, Monica Fornier, Larry Norton and Andrew J. Dannenberg. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, Expert Review of Anticancer Therapy and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.